An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 2

Conditions: Obesity

Treatments: Drug: MK0364

Study type: Interventional

Funder types: Industry

Identifiers

NCT00109148

2005_011

0364-006

Details and patient eligibility

About

The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).

Enrollment: 500 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are obese (considerably overweight) based on body mass index.

Exclusion criteria

• Patients with serious or unstable current or past medical conditions

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind